SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Fabian F. Sweeney, Olivia F. O'Leary, John F. Cryan, Activation but not blockade of GABAB receptors during early-life alters anxiety in adulthood in BALB/c mice, Neuropharmacology, 2014, 81, 303

    CrossRef

  2. 2
    Paul McGonigle, Animal models of CNS disorders, Biochemical Pharmacology, 2014, 87, 1, 140

    CrossRef

  3. 3
    Jéssica Pereira Costa, Guilherme Antônio L. de Oliveira, Antônia Amanda C. de Almeida, Md.Torequl Islam, Damião Pergentino de Sousa, Rivelilson Mendes de Freitas, Anxiolytic-like effects of phytol: Possible involvement of GABAergic transmission, Brain Research, 2014, 1547, 34

    CrossRef

  4. 4
    N.A. Andrews, M. Papakosta, N.M. Barnes, Discovery of novel anxiolytic agents — The trials and tribulations of pre-clinical models of anxiety, Neurobiology of Disease, 2014, 61, 72

    CrossRef

  5. 5
    Pradeep J Nathan, K Luan Phan, Catherine J Harmer, Mitul A Mehta, Edward T Bullmore, Increasing pharmacological knowledge about human neurological and psychiatric disorders through functional neuroimaging and its application in drug discovery, Current Opinion in Pharmacology, 2014, 14, 54

    CrossRef

  6. 6
    Hyungwoo Nam, Sarah M. Clinton, Nateka L. Jackson, Ilan A. Kerman, Learned helplessness and social avoidance in the Wistar-Kyoto rat, Frontiers in Behavioral Neuroscience, 2014, 8,

    CrossRef

  7. 7
    A Lotan, T Lifschytz, A Slonimsky, E C Broner, L Greenbaum, S Abedat, Y Fellig, H Cohen, O Lory, G Goelman, B Lerer, Neural mechanisms underlying stress resilience in Ahi1 knockout mice: relevance to neuropsychiatric disorders, Molecular Psychiatry, 2014, 19, 2, 243

    CrossRef

  8. 8
    Kevin K Ogden, Alpa Khatri, Stephen F Traynelis, Scott A Heldt, Potentiation of GluN2C/D NMDA Receptor Subtypes in the Amygdala Facilitates the Retention of Fear and Extinction Learning in Mice, Neuropsychopharmacology, 2014, 39, 3, 625

    CrossRef

  9. 9
    Allan V. Kalueff, Michael Nguyen, Testing anxiolytic drugs in the C57BL/6J mouse strain, Journal of Pharmacological and Toxicological Methods, 2014, 69, 2, 205

    CrossRef

  10. 10
    Nikolaos Pitsikas, The metabotropic glutamate receptors: Potential drug targets for the treatment of anxiety disorders?, European Journal of Pharmacology, 2014, 723, 181

    CrossRef

  11. 11
    Richard M. O'Connor, Deepak R. Thakker, Markus Schmutz, Herman van der Putten, Daniel Hoyer, Peter J. Flor, John F. Cryan, Adult siRNA-induced knockdown of mGlu7 receptors reduces anxiety in the mouse, Neuropharmacology, 2013, 72, 66

    CrossRef

  12. 12
    Lea R. Chioca, Valquíria D.C. Antunes, Marcelo M. Ferro, Estela M. Losso, Roberto Andreatini, Anosmia does not impair the anxiolytic-like effect of lavender essential oil inhalation in mice, Life Sciences, 2013, 92, 20-21, 971

    CrossRef

  13. 13
    María Celeste Bigliani, María Celeste Rosso, Paula M. Zunino, Gustavo Baiardi, Andrés Alberto Ponce, Anxiogenic-like effects ofUncariatomentosa(Willd.) DC. aqueous extract in an elevated plus maze test in mice: a preliminary study, Natural Product Research, 2013, 27, 18, 1682

    CrossRef

  14. 14
    Lea R. Chioca, Marcelo M. Ferro, Irinéia P. Baretta, Sara M. Oliveira, Cássia R. Silva, Juliano Ferreira, Estela M. Losso, Roberto Andreatini, Anxiolytic-like effect of lavender essential oil inhalation in mice: Participation of serotonergic but not GABAA/benzodiazepine neurotransmission, Journal of Ethnopharmacology, 2013, 147, 2, 412

    CrossRef

  15. 15
    Ryan Y Wong, Sarah E Oxendine, John Godwin, Behavioral and neurogenomic transcriptome changes in wild-derived zebrafish with fluoxetine treatment, BMC Genomics, 2013, 14, 1, 348

    CrossRef

  16. 16
    Xia Li, Victoria B. Risbrough, Chelsea Cates-Gatto, Katarzyna Kaczanowska, M.G. Finn, Amanda J. Roberts, Athina Markou, Comparison of the effects of the GABAB receptor positive modulator BHF177 and the GABAB receptor agonist baclofen on anxiety-like behavior, learning, and memory in mice, Neuropharmacology, 2013, 70, 156

    CrossRef

  17. 17
    Vincenzo Micale, Vincenzo Di Marzo, Alexandra Sulcova, Carsten T. Wotjak, Filippo Drago, Endocannabinoid system and mood disorders: Priming a target for new therapies, Pharmacology & Therapeutics, 2013, 138, 1, 18

    CrossRef

  18. 18
    Fabian F. Sweeney, Olivia F. O’Leary, John F. Cryan, GABAB receptor ligands do not modify conditioned fear responses in BALB/c mice, Behavioural Brain Research, 2013, 256, 151

    CrossRef

  19. 19
    Christine M. Tenk, Martin Kavaliers, Klaus-Peter Ossenkopp, Neonatal treatment with lipopolysaccharide differentially affects adult anxiety responses in the light–dark test and taste neophobia test in male and female rats, International Journal of Developmental Neuroscience, 2013, 31, 3, 171

    CrossRef

  20. 20
    Emerald Huang, Mai Ngo, Stuart Yee, Laura Held, Keith Norman, A.M. Erika Scremin, Oscar Scremin, Repeated blast exposure alters open field behavior recorded under low illumination, Brain Research, 2013, 1529, 125

    CrossRef

  21. 21
    G Clarke, S Grenham, P Scully, P Fitzgerald, R D Moloney, F Shanahan, T G Dinan, J F Cryan, The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner, Molecular Psychiatry, 2013, 18, 6, 666

    CrossRef

  22. 22
    Markus Fendt, Michael Koch, Translational value of startle modulations, Cell and Tissue Research, 2013, 354, 1, 287

    CrossRef

  23. 23
    Timothy P. O’Leary, Rhian K. Gunn, Richard E. Brown, What are We Measuring When We Test Strain Differences in Anxiety in Mice?, Behavior Genetics, 2013, 43, 1, 34

    CrossRef

  24. You have free access to this content24
    A. Richard Green, Jeffrey K. Aronson, An agenda for UK clinical pharmacology: From basic to clinical neuropharmacology: targetophilia or pharmacodynamics?, British Journal of Clinical Pharmacology, 2012, 73, 6
  25. 25
    R M O'Connor, T G Dinan, J F Cryan, Little things on which happiness depends: microRNAs as novel therapeutic targets for the treatment of anxiety and depression, Molecular Psychiatry, 2012, 17, 4, 359

    CrossRef

  26. 26
    John F. Cryan, Timothy G. Dinan, Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour, Nature Reviews Neuroscience, 2012, 13, 10, 701

    CrossRef

  27. 27
    J. F. Cryan, J. A. Bravo, T. G. Dinan, P. Forsythe, J. Bienenstock, Reply to McLean et al. and Burnet: The microbiome-gut-brain axis as a pathway toward next generation psychotropics, Proceedings of the National Academy of Sciences, 2012, 109, 4, E176

    CrossRef

  28. 28
    Alan M. Palmer, Mohammad S. Alavijeh, Translational CNS medicines research, Drug Discovery Today, 2012, 17, 19-20, 1068

    CrossRef

  29. 29
    Catherine Belzung, Maël Lemoine, Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression, Biology of Mood & Anxiety Disorders, 2011, 1, 1, 9

    CrossRef

  30. You have free access to this content30
    AR Green, J Gabrielsson, KCF Fone, Translational neuropharmacology and the appropriate and effective use of animal models, British Journal of Pharmacology, 2011, 164, 4